Sigma Healthcare Ltd
ASX:SIG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (2.3), the stock would be worth AU$0.99 (64% downside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 6.4 | AU$2.74 |
0%
|
| 3-Year Average | 2.3 | AU$0.99 |
-64%
|
| 5-Year Average | 1.5 | AU$0.64 |
-77%
|
| Industry Average | 3.3 | AU$1.39 |
-49%
|
| Country Average | 2.7 | AU$1.14 |
-58%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
31.9B AUD | 6.4 | 34.6 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
101.9B USD | -78.5 | 23.5 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
60.4B USD | 31.7 | 37.2 | |
| US |
|
Cencora Inc
NYSE:COR
|
60.3B USD | 31.7 | 37.2 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
47.8B USD | -16.6 | 28.7 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
61.9B CNY | 0.8 | 10.8 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.9B USD | 2.8 | 22.5 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
60B CNY | 2.5 | 21.2 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 6 | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
57.7B HKD | 0.6 | 7.2 | |
| DE |
M
|
McKesson Europe AG
XHAM:CLS1
|
5B EUR | 2.6 | -5.1 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.6 |
| Median | 2.7 |
| 70th Percentile | 4.3 |
| Max | 2 199.4 |
Other Multiples
Sigma Healthcare Ltd
Glance View
In the competitive landscape of Australia’s healthcare sector, Sigma Healthcare Ltd emerges as a vital cog in the country’s pharmacy and healthcare distribution wheel. Born from a humble beginning, the company has strategically evolved into one of the leading pharmaceutical wholesalers, boasting an extensive distribution network that spans across Australia's vast geography. Sigma supplies both prescription medicines and over-the-counter products to numerous independent and branded pharmacies, including recognizable names such as Amcal and Guardian. This distribution forte encapsulates Sigma’s primary revenue stream, as the company capitalizes on the efficiency of its supply chain operations, ensuring pharmaceuticals are delivered seamlessly from manufacturers directly to the doorsteps of pharmacies and hospitals. Beyond distribution, Sigma has diversified its operations to tap into retail pharmacy franchising, leveraging well-established brands to capture consumer loyalty. Operating under its banner of pharmacy brands, Sigma extends support in the form of marketing, retail advisory, and operational assistance to its franchise network, which in turn, feeds into its profitability margins. The company's strategic foresight into expanding its retail and service offerings further underpins its financial architecture, as it looks to balance its ledger not just through wholesale operations but also via the value-added services offered to its network. By orchestrating a symphony of merchandise management, supply chain prowess, and retail consultancy, Sigma Healthcare Ltd not only sustains its market relevance but also weaves itself deeply into the fabric of Australian healthcare delivery.